Extracorporeal liver support systems in patients with acute‐on‐chronic liver failure: An updated systematic review and meta‐analysis
Artificial Organs · 2025
DOI: 10.1111/aor.14915 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Artificial Organs, 2025. Verfasst von Haiyu Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, Fujian Medical University Union Hospital, Fuzhou, China. Hauptthemen laut MEDLINE: Acute-On-Chronic Liver Failure, Extracorporeal Membrane Oxygenation, Extracorporeal Circulation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fujian Province Natural Science Foundation Project (Project No. 2021J011293), Beijing Liver and Gallbladder Mutual-Aid Public Welfare Foundation Artificial Liver Special Fund(Project No. RGGJJ-2021-006), the Science and Technology Planning Project of Fuzhou (No. 2022-S-010).
Abstract (Originalsprache)
Background
The utilization of extracorporeal liver support systems is increasingly prevalent for the management of acute‐on‐chronic liver failure in clinical settings. Yet, the efficacy of these interventions in terms of tangible clinical benefits for patients remains a matter of debate, underscoring the need for meta‐analysis.
Methods
An updated meta‐analysis was performed to elucidate the relationship between the application of extracorporeal liver support versus standard pharmacological treatment and the prognostic endpoints of patient survival, specifically assessing 1‐month and 3‐month mortality rates, as well as the incidence of complications such as hepatic encephalopathy, spontaneous bacterial peritonitis, and hepatorenal syndrome. Literature were searched via PubMed, EMBASE, and Web of Science.
Results
The meta‐analysis revealed the following: the odds ratio for 1‐month mortality was 0.63 (95% confidence interval [CIs]: 0.51–0.76), for 3‐month mortality was 0.70 (95% CI: 0.61–0.81), for hepatic encephalopathy was 0.81 (95% CI: 0.67–0.97), for spontaneous bacterial peritonitis was 0.66 (95% CI: 0.44–0.99), and for hepatorenal syndrome was 0.68 (95% CI: 0.51–0.92). These results suggest that patients with acute‐on‐chronic liver failure undergoing extracorporeal liver support system therapy have significantly better survival rates and lower complication incidences compared to those receiving conventional drug therapy. Further subgroup analysis indicated that patients with lower model for end‐stage liver disease (MELD) scores and reduced total bilirubin (Tbil) levels demonstrated greater benefits from extracorporeal hepatic support.
Conclusion
This study establishes that in the management of acute‐on‐chronic liver failure, extracorporeal liver support systems confer a survival advantage and reduce complications relative to standard pharmacotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pulmonary and Critical Care Medicine, Fujian Medical University Union Hospital, Fuzhou, China.
- Department of Clinical Medicine, Clinical College of Anhui Medical University, Hefei, China.
- Department of Oncology Medicine, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China.
- Artificial Liver Center, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China.
- Department of Liver Diseases, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China.
ORCID-Profile: Jianhui Lin
Förderung
- Fujian Province Natural Science Foundation Project (Project No. 2021J011293)
- Beijing Liver and Gallbladder Mutual-Aid Public Welfare Foundation Artificial Liver Special Fund(Project No. RGGJJ-2021-006)
- the Science and Technology Planning Project of Fuzhou (No. 2022-S-010)
Zitieren
APA
Liu, H., Yang, Z., Luo, Q., & Lin, J. (2025). Extracorporeal liver support systems in patients with acute‐on‐chronic liver failure: An updated systematic review and meta‐analysis. Artificial Organs. https://doi.org/10.1111/aor.14915
Vancouver
Liu H, Yang Z, Luo Q, Lin J. Extracorporeal liver support systems in patients with acute‐on‐chronic liver failure: An updated systematic review and meta‐analysis. Artificial Organs. 2025. doi:10.1111/aor.14915
BibTeX
@article{Liu2025,
author = {Liu, Haiyu and Yang, Zhibo and Luo, Qiong and Lin, Jianhui},
title = {Extracorporeal liver support systems in patients with acute‐on‐chronic liver failure: An updated systematic review and meta‐analysis},
journal = {Artificial Organs},
year = {2025},
doi = {10.1111/aor.14915}
}
EUVIMED